nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminolevulinic acid—Brain oedema—Vandetanib—thyroid cancer	0.0471	0.0528	CcSEcCtD
Aminolevulinic acid—Hyperkeratosis—Sorafenib—thyroid cancer	0.0318	0.0356	CcSEcCtD
Aminolevulinic acid—ALAD—saliva-secreting gland—thyroid cancer	0.0312	0.291	CbGeAlD
Aminolevulinic acid—Dysaesthesia—Vandetanib—thyroid cancer	0.0311	0.0349	CcSEcCtD
Aminolevulinic acid—Skin cancer—Sorafenib—thyroid cancer	0.0293	0.0328	CcSEcCtD
Aminolevulinic acid—Thromboembolism—Sorafenib—thyroid cancer	0.0286	0.032	CcSEcCtD
Aminolevulinic acid—Amylase increased—Vandetanib—thyroid cancer	0.0283	0.0317	CcSEcCtD
Aminolevulinic acid—Amylase increased—Sorafenib—thyroid cancer	0.0191	0.0214	CcSEcCtD
Aminolevulinic acid—ALAD—thyroid gland—thyroid cancer	0.019	0.178	CbGeAlD
Aminolevulinic acid—Embolism venous—Sorafenib—thyroid cancer	0.018	0.0202	CcSEcCtD
Aminolevulinic acid—ALAD—head—thyroid cancer	0.0169	0.157	CbGeAlD
Aminolevulinic acid—Acne—Vandetanib—thyroid cancer	0.016	0.0179	CcSEcCtD
Aminolevulinic acid—Blood bilirubin increased—Vandetanib—thyroid cancer	0.0142	0.016	CcSEcCtD
Aminolevulinic acid—Embolism—Sorafenib—thyroid cancer	0.0142	0.0159	CcSEcCtD
Aminolevulinic acid—Respiratory failure—Vandetanib—thyroid cancer	0.0137	0.0154	CcSEcCtD
Aminolevulinic acid—Neoplasm—Vandetanib—thyroid cancer	0.0122	0.0136	CcSEcCtD
Aminolevulinic acid—ALAD—lymph node—thyroid cancer	0.0118	0.11	CbGeAlD
Aminolevulinic acid—Warmth—Epirubicin—thyroid cancer	0.0106	0.0118	CcSEcCtD
Aminolevulinic acid—Thromboembolism—Epirubicin—thyroid cancer	0.0106	0.0118	CcSEcCtD
Aminolevulinic acid—Warmth—Doxorubicin—thyroid cancer	0.00977	0.0109	CcSEcCtD
Aminolevulinic acid—Thromboembolism—Doxorubicin—thyroid cancer	0.00977	0.0109	CcSEcCtD
Aminolevulinic acid—Blood bilirubin increased—Sorafenib—thyroid cancer	0.00961	0.0108	CcSEcCtD
Aminolevulinic acid—Dry skin—Vandetanib—thyroid cancer	0.00896	0.01	CcSEcCtD
Aminolevulinic acid—Skin exfoliation—Sorafenib—thyroid cancer	0.00868	0.00972	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00862	0.00966	CcSEcCtD
Aminolevulinic acid—SLC15A2—saliva-secreting gland—thyroid cancer	0.00855	0.0798	CbGeAlD
Aminolevulinic acid—Neoplasm—Sorafenib—thyroid cancer	0.00822	0.0092	CcSEcCtD
Aminolevulinic acid—Leukoderma—Epirubicin—thyroid cancer	0.0079	0.00885	CcSEcCtD
Aminolevulinic acid—Dysaesthesia—Epirubicin—thyroid cancer	0.00777	0.0087	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00771	0.00864	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Vandetanib—thyroid cancer	0.00754	0.00844	CcSEcCtD
Aminolevulinic acid—Infestation—Vandetanib—thyroid cancer	0.00754	0.00844	CcSEcCtD
Aminolevulinic acid—Leukoderma—Doxorubicin—thyroid cancer	0.00731	0.00819	CcSEcCtD
Aminolevulinic acid—Dysaesthesia—Doxorubicin—thyroid cancer	0.00718	0.00805	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00713	0.00798	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Vandetanib—thyroid cancer	0.0068	0.00762	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Vandetanib—thyroid cancer	0.00676	0.00758	CcSEcCtD
Aminolevulinic acid—Embolism venous—Epirubicin—thyroid cancer	0.00665	0.00745	CcSEcCtD
Aminolevulinic acid—SLC15A2—trachea—thyroid cancer	0.0066	0.0616	CbGeAlD
Aminolevulinic acid—Eye disorder—Vandetanib—thyroid cancer	0.00632	0.00708	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Vandetanib—thyroid cancer	0.00628	0.00703	CcSEcCtD
Aminolevulinic acid—Embolism venous—Doxorubicin—thyroid cancer	0.00616	0.0069	CcSEcCtD
Aminolevulinic acid—Angiopathy—Vandetanib—thyroid cancer	0.00614	0.00687	CcSEcCtD
Aminolevulinic acid—Dry skin—Sorafenib—thyroid cancer	0.00605	0.00677	CcSEcCtD
Aminolevulinic acid—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00594	0.00665	CcSEcCtD
Aminolevulinic acid—Mental disorder—Vandetanib—thyroid cancer	0.00593	0.00664	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00582	0.00652	CcSEcCtD
Aminolevulinic acid—Skin hyperpigmentation—Epirubicin—thyroid cancer	0.00565	0.00632	CcSEcCtD
Aminolevulinic acid—Embolism—Epirubicin—thyroid cancer	0.00523	0.00586	CcSEcCtD
Aminolevulinic acid—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.00522	0.00585	CcSEcCtD
Aminolevulinic acid—SLC15A2—thyroid gland—thyroid cancer	0.00522	0.0487	CbGeAlD
Aminolevulinic acid—Convulsion—Vandetanib—thyroid cancer	0.0051	0.00571	CcSEcCtD
Aminolevulinic acid—Infestation—Sorafenib—thyroid cancer	0.00508	0.00569	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Sorafenib—thyroid cancer	0.00508	0.00569	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00498	0.00558	CcSEcCtD
Aminolevulinic acid—Seborrhoeic dermatitis—Epirubicin—thyroid cancer	0.00493	0.00552	CcSEcCtD
Aminolevulinic acid—Embolism—Doxorubicin—thyroid cancer	0.00484	0.00542	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00481	0.00538	CcSEcCtD
Aminolevulinic acid—Oedema—Vandetanib—thyroid cancer	0.00481	0.00538	CcSEcCtD
Aminolevulinic acid—Infection—Vandetanib—thyroid cancer	0.00477	0.00535	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Vandetanib—thyroid cancer	0.00471	0.00528	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Vandetanib—thyroid cancer	0.00471	0.00527	CcSEcCtD
Aminolevulinic acid—Skin disorder—Vandetanib—thyroid cancer	0.00467	0.00523	CcSEcCtD
Aminolevulinic acid—SLC15A2—head—thyroid cancer	0.00463	0.0432	CbGeAlD
Aminolevulinic acid—Haemoglobin—Sorafenib—thyroid cancer	0.00459	0.00514	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Sorafenib—thyroid cancer	0.00456	0.00511	CcSEcCtD
Aminolevulinic acid—Seborrhoeic dermatitis—Doxorubicin—thyroid cancer	0.00456	0.00511	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Vandetanib—thyroid cancer	0.00432	0.00483	CcSEcCtD
Aminolevulinic acid—Hyperaesthesia—Epirubicin—thyroid cancer	0.00428	0.00479	CcSEcCtD
Aminolevulinic acid—Feeling hot—Epirubicin—thyroid cancer	0.00428	0.00479	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Sorafenib—thyroid cancer	0.00424	0.00474	CcSEcCtD
Aminolevulinic acid—Rash pustular—Epirubicin—thyroid cancer	0.00421	0.00472	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00415	0.00465	CcSEcCtD
Aminolevulinic acid—Stinging—Epirubicin—thyroid cancer	0.00415	0.00464	CcSEcCtD
Aminolevulinic acid—Angiopathy—Sorafenib—thyroid cancer	0.00414	0.00464	CcSEcCtD
Aminolevulinic acid—Pain—Vandetanib—thyroid cancer	0.00411	0.0046	CcSEcCtD
Aminolevulinic acid—Petechiae—Epirubicin—thyroid cancer	0.00408	0.00457	CcSEcCtD
Aminolevulinic acid—Mental disorder—Sorafenib—thyroid cancer	0.004	0.00448	CcSEcCtD
Aminolevulinic acid—Erythema—Sorafenib—thyroid cancer	0.00397	0.00445	CcSEcCtD
Aminolevulinic acid—Hyperaesthesia—Doxorubicin—thyroid cancer	0.00396	0.00443	CcSEcCtD
Aminolevulinic acid—Feeling hot—Doxorubicin—thyroid cancer	0.00396	0.00443	CcSEcCtD
Aminolevulinic acid—Rash pustular—Doxorubicin—thyroid cancer	0.0039	0.00436	CcSEcCtD
Aminolevulinic acid—Stinging—Doxorubicin—thyroid cancer	0.00384	0.0043	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Vandetanib—thyroid cancer	0.0038	0.00426	CcSEcCtD
Aminolevulinic acid—Petechiae—Doxorubicin—thyroid cancer	0.00378	0.00423	CcSEcCtD
Aminolevulinic acid—Anaemia—Sorafenib—thyroid cancer	0.00367	0.00411	CcSEcCtD
Aminolevulinic acid—Herpes simplex—Epirubicin—thyroid cancer	0.00364	0.00408	CcSEcCtD
Aminolevulinic acid—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00355	0.00398	CcSEcCtD
Aminolevulinic acid—Ulcer—Epirubicin—thyroid cancer	0.00355	0.00398	CcSEcCtD
Aminolevulinic acid—Pruritus—Vandetanib—thyroid cancer	0.0034	0.00381	CcSEcCtD
Aminolevulinic acid—Herpes simplex—Doxorubicin—thyroid cancer	0.00337	0.00378	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00336	0.00376	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Vandetanib—thyroid cancer	0.00329	0.00368	CcSEcCtD
Aminolevulinic acid—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00329	0.00368	CcSEcCtD
Aminolevulinic acid—Ulcer—Doxorubicin—thyroid cancer	0.00329	0.00368	CcSEcCtD
Aminolevulinic acid—SLC15A2—lymph node—thyroid cancer	0.00324	0.0303	CbGeAlD
Aminolevulinic acid—Infection—Sorafenib—thyroid cancer	0.00322	0.00361	CcSEcCtD
Aminolevulinic acid—Skin exfoliation—Epirubicin—thyroid cancer	0.00321	0.00359	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Sorafenib—thyroid cancer	0.00318	0.00356	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Sorafenib—thyroid cancer	0.00317	0.00356	CcSEcCtD
Aminolevulinic acid—Skin disorder—Sorafenib—thyroid cancer	0.00315	0.00353	CcSEcCtD
Aminolevulinic acid—Vomiting—Vandetanib—thyroid cancer	0.00306	0.00342	CcSEcCtD
Aminolevulinic acid—Rash maculo-papular—Epirubicin—thyroid cancer	0.00305	0.00342	CcSEcCtD
Aminolevulinic acid—Neoplasm—Epirubicin—thyroid cancer	0.00304	0.0034	CcSEcCtD
Aminolevulinic acid—Rash—Vandetanib—thyroid cancer	0.00303	0.00339	CcSEcCtD
Aminolevulinic acid—Dermatitis—Vandetanib—thyroid cancer	0.00303	0.00339	CcSEcCtD
Aminolevulinic acid—Headache—Vandetanib—thyroid cancer	0.00301	0.00337	CcSEcCtD
Aminolevulinic acid—Skin exfoliation—Doxorubicin—thyroid cancer	0.00297	0.00332	CcSEcCtD
Aminolevulinic acid—Nausea—Vandetanib—thyroid cancer	0.00285	0.0032	CcSEcCtD
Aminolevulinic acid—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00282	0.00316	CcSEcCtD
Aminolevulinic acid—Neoplasm—Doxorubicin—thyroid cancer	0.00281	0.00315	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0028	0.00313	CcSEcCtD
Aminolevulinic acid—Photosensitivity—Epirubicin—thyroid cancer	0.00278	0.00311	CcSEcCtD
Aminolevulinic acid—Pain—Sorafenib—thyroid cancer	0.00277	0.00311	CcSEcCtD
Aminolevulinic acid—Urticaria—Sorafenib—thyroid cancer	0.00258	0.00288	CcSEcCtD
Aminolevulinic acid—Photosensitivity—Doxorubicin—thyroid cancer	0.00257	0.00288	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Sorafenib—thyroid cancer	0.00256	0.00287	CcSEcCtD
Aminolevulinic acid—Pruritus—Sorafenib—thyroid cancer	0.00229	0.00257	CcSEcCtD
Aminolevulinic acid—Dry skin—Epirubicin—thyroid cancer	0.00223	0.0025	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Sorafenib—thyroid cancer	0.00222	0.00248	CcSEcCtD
Aminolevulinic acid—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.0022	0.00246	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00215	0.00241	CcSEcCtD
Aminolevulinic acid—Dry skin—Doxorubicin—thyroid cancer	0.00207	0.00232	CcSEcCtD
Aminolevulinic acid—Vomiting—Sorafenib—thyroid cancer	0.00206	0.00231	CcSEcCtD
Aminolevulinic acid—Rash—Sorafenib—thyroid cancer	0.00204	0.00229	CcSEcCtD
Aminolevulinic acid—Dermatitis—Sorafenib—thyroid cancer	0.00204	0.00229	CcSEcCtD
Aminolevulinic acid—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00203	0.00227	CcSEcCtD
Aminolevulinic acid—Headache—Sorafenib—thyroid cancer	0.00203	0.00227	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00199	0.00223	CcSEcCtD
Aminolevulinic acid—Nausea—Sorafenib—thyroid cancer	0.00193	0.00216	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00192	0.00215	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Epirubicin—thyroid cancer	0.00188	0.0021	CcSEcCtD
Aminolevulinic acid—Infestation—Epirubicin—thyroid cancer	0.00188	0.0021	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00178	0.00199	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00178	0.00199	CcSEcCtD
Aminolevulinic acid—Infestation—Doxorubicin—thyroid cancer	0.00174	0.00195	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Doxorubicin—thyroid cancer	0.00174	0.00195	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Epirubicin—thyroid cancer	0.0017	0.0019	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Epirubicin—thyroid cancer	0.00169	0.00189	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Epirubicin—thyroid cancer	0.00168	0.00188	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00164	0.00184	CcSEcCtD
Aminolevulinic acid—Eye disorder—Epirubicin—thyroid cancer	0.00158	0.00177	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Doxorubicin—thyroid cancer	0.00157	0.00176	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Epirubicin—thyroid cancer	0.00157	0.00175	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Doxorubicin—thyroid cancer	0.00156	0.00175	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00155	0.00174	CcSEcCtD
Aminolevulinic acid—Angiopathy—Epirubicin—thyroid cancer	0.00153	0.00171	CcSEcCtD
Aminolevulinic acid—Chills—Epirubicin—thyroid cancer	0.00151	0.00169	CcSEcCtD
Aminolevulinic acid—Mental disorder—Epirubicin—thyroid cancer	0.00148	0.00165	CcSEcCtD
Aminolevulinic acid—Erythema—Epirubicin—thyroid cancer	0.00147	0.00164	CcSEcCtD
Aminolevulinic acid—Eye disorder—Doxorubicin—thyroid cancer	0.00146	0.00163	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Doxorubicin—thyroid cancer	0.00145	0.00162	CcSEcCtD
Aminolevulinic acid—Tension—Epirubicin—thyroid cancer	0.00144	0.00161	CcSEcCtD
Aminolevulinic acid—Nervousness—Epirubicin—thyroid cancer	0.00143	0.0016	CcSEcCtD
Aminolevulinic acid—Angiopathy—Doxorubicin—thyroid cancer	0.00142	0.00159	CcSEcCtD
Aminolevulinic acid—Chills—Doxorubicin—thyroid cancer	0.0014	0.00157	CcSEcCtD
Aminolevulinic acid—Mental disorder—Doxorubicin—thyroid cancer	0.00137	0.00153	CcSEcCtD
Aminolevulinic acid—Erythema—Doxorubicin—thyroid cancer	0.00136	0.00152	CcSEcCtD
Aminolevulinic acid—Anaemia—Epirubicin—thyroid cancer	0.00136	0.00152	CcSEcCtD
Aminolevulinic acid—Tension—Doxorubicin—thyroid cancer	0.00133	0.00149	CcSEcCtD
Aminolevulinic acid—Nervousness—Doxorubicin—thyroid cancer	0.00132	0.00148	CcSEcCtD
Aminolevulinic acid—Convulsion—Epirubicin—thyroid cancer	0.00127	0.00142	CcSEcCtD
Aminolevulinic acid—Anaemia—Doxorubicin—thyroid cancer	0.00126	0.00141	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00124	0.00139	CcSEcCtD
Aminolevulinic acid—Discomfort—Epirubicin—thyroid cancer	0.00123	0.00138	CcSEcCtD
Aminolevulinic acid—Oedema—Epirubicin—thyroid cancer	0.0012	0.00134	CcSEcCtD
Aminolevulinic acid—Infection—Epirubicin—thyroid cancer	0.00119	0.00133	CcSEcCtD
Aminolevulinic acid—Convulsion—Doxorubicin—thyroid cancer	0.00118	0.00132	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Epirubicin—thyroid cancer	0.00117	0.00132	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Epirubicin—thyroid cancer	0.00117	0.00131	CcSEcCtD
Aminolevulinic acid—Skin disorder—Epirubicin—thyroid cancer	0.00116	0.0013	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00115	0.00129	CcSEcCtD
Aminolevulinic acid—Discomfort—Doxorubicin—thyroid cancer	0.00114	0.00128	CcSEcCtD
Aminolevulinic acid—Hypotension—Epirubicin—thyroid cancer	0.00112	0.00125	CcSEcCtD
Aminolevulinic acid—Oedema—Doxorubicin—thyroid cancer	0.00111	0.00124	CcSEcCtD
Aminolevulinic acid—Infection—Doxorubicin—thyroid cancer	0.0011	0.00123	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Doxorubicin—thyroid cancer	0.00109	0.00122	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00109	0.00122	CcSEcCtD
Aminolevulinic acid—Skin disorder—Doxorubicin—thyroid cancer	0.00108	0.00121	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Epirubicin—thyroid cancer	0.00108	0.0012	CcSEcCtD
Aminolevulinic acid—Hypotension—Doxorubicin—thyroid cancer	0.00104	0.00116	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00103	0.00116	CcSEcCtD
Aminolevulinic acid—Pain—Epirubicin—thyroid cancer	0.00102	0.00115	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Doxorubicin—thyroid cancer	0.000995	0.00111	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000957	0.00107	CcSEcCtD
Aminolevulinic acid—Urticaria—Epirubicin—thyroid cancer	0.000952	0.00107	CcSEcCtD
Aminolevulinic acid—Pain—Doxorubicin—thyroid cancer	0.000948	0.00106	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Epirubicin—thyroid cancer	0.000947	0.00106	CcSEcCtD
Aminolevulinic acid—Urticaria—Doxorubicin—thyroid cancer	0.000881	0.000986	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Doxorubicin—thyroid cancer	0.000876	0.000982	CcSEcCtD
Aminolevulinic acid—Pruritus—Epirubicin—thyroid cancer	0.000848	0.000949	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Epirubicin—thyroid cancer	0.00082	0.000918	CcSEcCtD
Aminolevulinic acid—Pruritus—Doxorubicin—thyroid cancer	0.000784	0.000878	CcSEcCtD
Aminolevulinic acid—Vomiting—Epirubicin—thyroid cancer	0.000762	0.000853	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Doxorubicin—thyroid cancer	0.000759	0.00085	CcSEcCtD
Aminolevulinic acid—Rash—Epirubicin—thyroid cancer	0.000755	0.000846	CcSEcCtD
Aminolevulinic acid—Dermatitis—Epirubicin—thyroid cancer	0.000755	0.000845	CcSEcCtD
Aminolevulinic acid—Headache—Epirubicin—thyroid cancer	0.000751	0.000841	CcSEcCtD
Aminolevulinic acid—Nausea—Epirubicin—thyroid cancer	0.000712	0.000797	CcSEcCtD
Aminolevulinic acid—Vomiting—Doxorubicin—thyroid cancer	0.000705	0.000789	CcSEcCtD
Aminolevulinic acid—Rash—Doxorubicin—thyroid cancer	0.000699	0.000783	CcSEcCtD
Aminolevulinic acid—Dermatitis—Doxorubicin—thyroid cancer	0.000698	0.000782	CcSEcCtD
Aminolevulinic acid—Headache—Doxorubicin—thyroid cancer	0.000695	0.000778	CcSEcCtD
Aminolevulinic acid—Nausea—Doxorubicin—thyroid cancer	0.000659	0.000738	CcSEcCtD
